ArticleThe Journal of international medical research2022

CD5+ diffuse large B-cell lymphoma has heterogeneous clinical features and poor prognosis: a single-center retrospective study in China.

Ting Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.